Navigation Links
Members of Congress and Disability Rights Advocates Support the Restoration of the Americans with Disabilities Act and Welcome Back the Road To Freedom Bus
Date:11/14/2007

Yearlong, 50-State Disability Rights Bus Tour and Traveling Exhibit Returns to Washington, DC

WASHINGTON, Nov. 14 /PRNewswire-USNewswire/ -- Senator Tom Harkin and other members of Congress will join Yoshiko Dart and disability rights leaders to welcome back The Road To Freedom: Keeping the Promise of the Americans with Disabilities Act (ADA), a yearlong, cross-country bus tour and traveling exhibit promoting the civil rights of people with disabilities and advocating for passage of the ADA Restoration Act of 2007. This legislation will restore the vital civil rights protections under the ADA that have been weakened in the courts in recent years. A U.S. Senate hearing on the ADA Restoration Act of 2007 has been scheduled to coincide with the return of the Road To Freedom bus to Washington, DC on November 15, 2007.

With Yoshiko Dart, widow of the late disability rights leader Justin Dart onboard for the first leg of the journey, the Road To Freedom bus tour launched from Washington on November 15th of 2006 and has traveled to all 50 states, driving more than 25,000 miles to more than 100 bus stop events. Road To Freedom events have included disability leaders and U.S. Senators, Members of Congress, Governors and other policymakers at sites such as the National Civil Rights Museum, Brown v. Board of Education Historic Site, Clinton Presidential Library, Mount Rushmore, as well as statehouses, city halls, museums, churches, colleges, and schools throughout the country.

Join us to welcome the Road To Freedom Bus back to Washington, show your support for the Americans with Disabilities Act (ADA) and attend the Senate Hearing on the ADA Restoration Act of 2007.

What:

Support the ADA at the Road To Freedom Bus Stop at the U.S. Capitol and attend the Senate hearing on the ADA Restoration Act

When:

November 15, 2007

11:00 AM - 1:00 PM: Bus and Exhibit of Disability Rights History, welcome from Senator Tom Harkin
'/>"/>

SOURCE ADA Watch and the National Coalition for Disability Rights
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. AARP Poll: California Members Want Health Care Reform THIS YEAR
2. AARP Launches New Fitness Website for AARP Members - AARPfitness.com
3. Independence Blue Cross Makes Music for Members Ears
4. National Association for Home Care & Hospice (NAHC) Members Take Their Case to Capitol Hill
5. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
6. Union Members Hold Demonstrations at Philadelphia Nursing Home
7. Health Care Service Corporation Provides Personal Clinical Summaries to Members of its Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas
8. Shop n Save Pharmacy Helps Vitalize Members of Wellness-based Health Insurance Plan
9. EHRVA Members Collaborate to Demonstrate Interoperability Success at NCHICA
10. CIGNA Behavioral Health Offers Members Online Provider Profiles
11. New Members Named to URACs Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)...POLIS, May 15 /PRNewswire-FirstCall/ -- Lung cance...ent decisions may fare better as a,result, accordi...er (NSCLC),clinical trial. Data from the trial, wh...metrexed for injection), will be presented at the ...nical Oncology (ASCO) in Chicago,Ill., May 30 -- ...
(Date:5/15/2008)...n, DC -- With the goal of tailoring cancer treatme...University Medical Center today presented a study ...re reliably assess treatment efficacy for patients...veral weeks and sometimes months to determine if a... can take that long to observe any significant rad...
(Date:5/15/2008)...USTON - Celecoxib, the anti-inflammatory medicatio...n to be safe and reduces a specific proliferation ...ccording to a study from The University of Texas M...ates the significance of COX-2 inhibition toward p...k of developing the disease. , The study is the ...
(Date:5/15/2008)..., China, May 15 /Xinhua-PRNewswire-FirstCall/ -- G...etin Board: GTEC) ("Genesis" or,the "Company"), a ...rations,in the People,s Republic of China, today a...ed March 31, 2008, the Company,s third quarter of ...was filed for the quarter,with the U.S. Securities...
Breaking Medicine News(10 mins):Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 2Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 3Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 4Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 5Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 6Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 7Health News:Study suggests blood test can help improve treatment outcomes for breast cancer patients 2Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 2Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 3Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 2Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 3Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 4Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 5Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 6Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 7Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 8Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 9Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 10Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 11Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 12
...esearch and Learning Disabilities and Prof. Baruch...niversity of Haifa have developed a standardized t...lities. The project was headed by Prof. Zvia Bre...Brain Research and Learning Disabilities at the Un...
...ducing obesity among American consumers, but some ...beneficial in the battle against the bulge accordi...hed monthly by the Institute of Food Technologists...cent food science, nutrition and metabolic researc...
...y provide effective protection against HIV was wel...HO) and the UNAIDS Secretariat. It follows public...Kenya and Uganda in the medical journal The Lancet...er study by the South Africa Orange Farm Intervent...
...n-one fixed dose combination Atripla in 66 develop...th Organization prequalification for the product, ...is a single tablet containing a daily dose of efav...ll be priced at $613 a year for least developed co...
Other Medicine News:Health News:Standardized Diagnostic Test for Learning Disabilities 2Health News:Merck Announces Plans for Licensing Atripla Widely in Developing World 2
(Date:5/15/2008)...leared device to identify the, lipid core (fatty)...with complications of coronary s...- InfraReDx, Inc. today,announced that physicians ...cessfully used its LipiScan(TM) Coronary Imaging S...ation. This is the first patient in the,world in w...
(Date:5/15/2008).../ -- Tigris Pharmaceuticals,Inc. announced today ...pment Agreement (CRADA) with the National Cancer I...linical development of AFP-464, an,aminoflavone cu...ed to,metabolites which bind covalently to DNA, re... part of a four-year CRADA encompassing multiple P...
(Date:5/15/2008)...l data reports in third quarter ...ire-FirstCall/ -- VIA Pharmaceuticals,Inc. (Nasda... development of,compounds for the treatment of car...ompleted patient enrollment in its acute coronary ...e Phase 2 trials investigating VIA-2291,the compa...
(Date:5/14/2008)...FirstCall/ -- Progen,Pharmaceuticals Limited (ASX:...y has resumed patient enrolment in the phase 1 dos...ine analogue, PG-11047 (formerly CGC-11047),for pa...d development of PG-11047 - the lead clinical,comp...g its acquisition of,Cellgate, Inc earlier this ye...
Breaking Medicine Technology:First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047 2Novel method to reveal drug targets 12458 1Novel method to reveal drug targets 12458 2Novel method to reveal drug targets 12458 3John OConnell Joins Finesse Solutions as Vice President of Sales and Business Development 12453 1Wyeths XYNTHA Approved by FDA for Treatment of Hemophilia A 12448 1Wyeths XYNTHA Approved by FDA for Treatment of Hemophilia A 12448 2Wyeths XYNTHA Approved by FDA for Treatment of Hemophilia A 12448 3Wyeths XYNTHA Approved by FDA for Treatment of Hemophilia A 12448 4U S Court Approves AK Steels VEBA Health Care Settlement With Middletown Works Retirees 12444 1U S Court Approves AK Steels VEBA Health Care Settlement With Middletown Works Retirees 12444 2
...HAMBURG, Germany, May 03, 2007 /PRNewswire/ -- At ... data which provide a sound,scientific basis for a...n patients. , Tumor tissue-derived primary cell li... testing. During their clonal selection and,expans...tterns,change significantly, thereby losing many o...
...BOSTON, May 03, 2007 /PRNewswire/ -- Bayer HealthC... three clinical,studies with Betaseron(R) (interfe...Academy of Neurology,s (AAN) 59th Annual Meeting,...ty, and high,patient satisfaction with treatment i...sis (MS). , "Collectively, these studies highlight...
Other Medicine Technology:Indivumed Study Provides Sound Scientific Basis for a Predictive,Drug Test- Platform 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 3Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 4
...hysiology imaging have become more acute. The nee...exposure to both patient and staff has become para...ems. In keeping with Omegas goal of maintaining i..., four bi-plane imaging configurations are availab...
...ice efficiency by reducing errors and eliminating ...diology software solution, you can spend less time... time on your patient care. Cardiology software fr...r 50,000 installations and a long track record of ...
...ates an integrated Medical Records and Transcripti...d by the national Health Care HL7 communications p...ormation insurers and physician inter-office commu...ectronic exchange of Patient medical records, Demo...
... is a Web Browser-based Ambulatory software suite ...tronic Medical Record (EMR) and Managed Care solut...and for dependable HIPAA-era management software, ... software products and services that provide a sec...
Medicine Products: